Cargando…
Nasal spray (Zavegepant) for migraines: a mini-review
Neurological disorders, especially migraines, pose a significant global burden. This has driven the recent innovative research being conducted in the field of anti-migraine therapies, including the discovery of Zavegepant for the treatment of acute migraine attacks. Zavegepant is a novel, first-in-c...
Autores principales: | Larik, Muhammad Omar, Iftekhar, Muhammad Ashhal, Syed, Bilal Ulhassan, Ansari, Omema, Ansari, Mozaena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289569/ https://www.ncbi.nlm.nih.gov/pubmed/37363553 http://dx.doi.org/10.1097/MS9.0000000000000843 |
Ejemplares similares
-
Zavegepant nasal spray for the acute treatment of migraine: A meta analysis
por: Waqas, Muhammad, et al.
Publicado: (2023) -
Safety and Efficacy of Zavegepant in Treating Migraine: A Systematic Review
por: Khan, Zainab Z, et al.
Publicado: (2023) -
Bombay Blood Group Phenotype Misdiagnosed As O Phenotype: A Case Report
por: Qadir, Hira, et al.
Publicado: (2023) -
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
por: Croop, Robert, et al.
Publicado: (2022) -
Zavegepant: First Approval
por: Dhillon, Sohita
Publicado: (2023)